SCHEMBL7973444

SCHEMBL7973444

CN(Cc1ccccc1)c1ncc2ncncc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 1/20 0.47
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
PIK3CD O00329 1/20 0.41
PIK3R1 P27986 1/20 0.41
HTT P42858 1/20 0.41
HIF1A Q16665 1/20 0.41
ALDH1A1 P00352 5/20 0.40
PDE5A O76074 1/20 0.39
KDM4E B2RXH2 2/20 0.38
TSHR P16473 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
PKM P14618 1/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7948937 0.85 EGFR (0.40) RPS6KB1LMNAALDH1A1TSHRCYP1A2
SCHEMBL8132510 0.74 LMNA (0.53) RPS6KB1LMNASMN1; SMN2PIK3CDPIK3R1
SCHEMBL30092928 0.73 PDE4A (0.44) RPS6KB1ALDH1A1PDE5AKDM4ETSHR
SCHEMBL19145083 0.72 ALDH1A1 (0.47) RPS6KB1LMNASMN1; SMN2ALDH1A1KDM4E
SCHEMBL12889093 0.70 ALDH1A1 (0.54) LMNASMN1; SMN2ALDH1A1PDE5AKDM4E
SCHEMBL20394335 0.70 LMNA (0.48) RPS6KB1LMNASMN1; SMN2PIK3CDPIK3R1
SCHEMBL20406386 0.70 ALDH1A1 (0.45) LMNASMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL27855245 0.70 TSHR (0.48) LMNASMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL8127484 0.69 EGFR (0.50) RPS6KB1LMNASMN1; SMN2HTTALDH1A1
SCHEMBL30775396 0.69 CSF1R (0.49) RPS6KB1LMNASMN1; SMN2PIK3CDPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6297250-B1 USEFUL FOR INHIBITING TRANSPORT OF NUCLEOSIDES OR PURINES ACROSS CELL MEMBRANES, THEREBY TO POTENTIATE THE ACTIVITY OF VARIOUS CYTOTOXIC ANTITUMOR DRUGS NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 2001-10-02 US claimed